PerkinElmer, Inc has announced the launch of two Research Use Only (RUO) solutions, PKamp™ VariantDetect&trad...
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that the Company has c...
BWXT Medical Ltd. and Global Medical Solutions, Ltd. (GMS) have entered into a joint venture (JV) to manufacture and dis...
The U.S. Food and Drug Administration on March 5th 2021 issued an emergency use authorization (EUA) for the T-Detect COV...
Japanese firm Eisai Co., Ltd. announced that it has decided to assent to and support a project led by CA Medlynks Kenya,...
Gaithersburg-based Saint-Gobain Life Sciences in the US is an industry leader in material science-based solutions f...
Waters Corporation has entered a reseller agreement with TetraScience, a cloud technology innovator powering transf...
PerkinElmer, Inc, has launched the PerkinElmer® COVID-19 Antigen Test for the qualitative detect...
Gavi, the Vaccine Alliance announced today that it had signed a memorandum of understanding (MoU) with Novavax that, com...
Pelican BioThermal, the global name in temperature-controlled packaging, partners with industry experts to offer Innovat...
Agilent Technologies Inc. has announced the launch of the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent A...
Significant advances to the diagnosis of tuberculosis (TB) and drug resistance in adults, adolescents and children are...
The Vanquish Online 2D-LC system leverages the performance and ease of use of the innovative Vanquish technology, while ...
The World Federation of Neurology is pleased to announce its launch of the Brain Health Initiative, a global campaign to...
Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products has announced that...
GenScript USA Inc., the world's leading life science research tools and services provider, announced today that it has r...
WHo at a media briefing on Feb 10, 2021, updated that globally around 128 million vaccine doses administered so far and ...
The US Food and Drug Administration has issued an emergency use authorisation (EUA) for bamlanivimab and etese...
